Lista de obras -

A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats

artículo científico publicado en 2016

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

artículo científico publicado en 2016

A proof of concept for structure-based vaccine design targeting RSV in humans

scientific article published on 01 August 2019

A subset of membrane-altering agents and γ-secretase modulators provoke nonsubstrate cleavage by rhomboid proteases

artículo científico publicado en 2014

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

artículo científico publicado en 2015

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

artículo científico publicado en 2019

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

artículo científico publicado en 2015

Immunomodulation Induced by Host Pathogen Interaction

scientific article published on 29 August 2019

Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.

artículo científico publicado en 2017

Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation

artículo científico publicado en 2018

Intramembrane proteolysis of Toxoplasma apical membrane antigen 1 facilitates host-cell invasion but is dispensable for replication.

artículo científico publicado en 2012

Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.

artículo científico publicado en 2016

Membrane immersion allows rhomboid proteases to achieve specificity by reading transmembrane segment dynamics.

artículo científico publicado en 2012

Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.

scientific article published on 31 August 2016

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors

artículo científico publicado en 2016

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.

artículo científico publicado en 2017

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

artículo científico publicado en 2013

The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.

artículo científico publicado en 2009

The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.

artículo científico publicado en 2007

Lista de obras de

A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

A proof of concept for structure-based vaccine design targeting RSV in humans

A subset of membrane-altering agents and γ-secretase modulators provoke nonsubstrate cleavage by rhomboid proteases

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

Immunomodulation Induced by Host Pathogen Interaction

Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.

Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation

Intramembrane proteolysis of Toxoplasma apical membrane antigen 1 facilitates host-cell invasion but is dispensable for replication.

Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.

Membrane immersion allows rhomboid proteases to achieve specificity by reading transmembrane segment dynamics.

Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.

The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.